Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 46:503-507, December 2005
doi: 10.1176/appi.psy.46.6.503
© 2005 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Leo, R. J.
* Articles by Baer, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Leo, R. J.
* Articles by Baer, D.
Related Collections
* Syndromes Secondary to General Medical Disorders
* Symptoms/Dimensions
* Other Somatic Therapy

Review

Delirium Associated With Baclofen Withdrawal: A Review of Common Presentations and Management Strategies

Raphael J. Leo, M.D., F.A.P.M., and Daniel Baer, M.D.

Received May 28, 2004; revision received Oct. 9, 2004; accepted Oct. 28, 2004. From the Department of Psychiatry, School of Medicine and Biomedical Sciences, State University of New York at Buffalo. Address correspondence and reprint requests to Dr. Leo, Department of Psychiatry, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Erie County Medical Center, 462 Grider Street Buffalo, NY 14215; rleomd{at}aol.com (e-mail).

The authors reviewed 23 published cases of psychiatric symptoms in association with baclofen withdrawal. Delirium, and not other functional psychiatric conditions, arose secondarily from abrupt baclofen cessation. Vulnerability to baclofen-withdrawal delirium appeared to be greater in individuals who received chronic baclofen therapy. Baclofen-withdrawal delirium can be difficult to distinguish from delirium of other etiologies, and unrecognized and inadequately treated baclofen-withdrawal delirium is associated with significant morbidity and mortality. Complete resolution of delirium symptoms was possible with reinstatement of baclofen. The clinical management of patients experiencing baclofen-withdrawal delirium includes supportive interventions to reduce complications of delirium until symptoms resolve.

Key Words: Baclofen • antispasmodics • delirium • muscle relaxants • withdrawal




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
J. M. Chawla, R. Rao, and R. Sagar
Baclofen-Induced Psychosis
Ann. Pharmacother., November 1, 2006; 40(11): 2071 - 2073.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org